核因子E2相关因子2抗氧化通路与肝脏疾病的关系

贺国娜; 申风俊

doi:10.3969/j.issn.1001-5256.2019.04.050

核因子E2相关因子2抗氧化通路与肝脏疾病的关系

DOI: 10.3969/j.issn.1001-5256.2019.04.050

山西医科大学第一医院消化科

基金项目:

山西省科技厅资助项目(201701D22111180)；

详细信息

中图分类号: R575
计量
- 文章访问数: 1910
- HTML全文浏览量: 15
- PDF下载量: 259
- 被引次数: 0
出版历程
- 出版日期: 2019-04-20

Association between nuclear factor-erythroid 2-related factor-2 antioxidant pathway and liver diseases

Department of Gastroenterology, The First Hospital of Shanxi Medical University

Research funding:

摘要

摘要: 核因子E2相关因子2（Nrf2）是细胞抵御氧化应激的一个重要转录因子,其与抗氧化反应元件相互作用,从而诱导下游保护性II相解毒酶和抗氧化酶的表达,起到细胞的保护作用。氧化应激是众多肝脏疾病共同的发病机制,而Nrf2-抗氧化反应元件是体内重要的抗氧化应激通路,该通路通过诱导下游靶基因的表达,在肝脏疾病的发生、发展及预防过程中起重要作用。简述了Nrf2抗氧化通路在肝脏疾病发生发展过程中的作用机制。认为Nrf2可能成为预防或治疗肝脏疾病的一个潜在靶点。
- 肝疾病 /
- NF-E2相关因子2 /
- 氧化性应激 /
- 综述
Abstract: Nuclear factor-erythroid 2-related factor-2 ( Nrf2) is an important transcription factor for cells to resist oxidative stress. It interacts with antioxidant response elements to induce the expression of downstream protective phase II detoxification enzymes and antioxidant enzymes and thus exerts a protective effect on cells. Oxidative stress is the common pathogenesis of many liver diseases, and the Nrf2-ARE antioxidant pathway is an important anti-oxidative stress pathway in vivo. It can induce the expression of downstream target genes and thus plays an important role in the development, progression, and prevention of liver diseases. This article briefly describes the mechanism of action of the Nrf2 antioxidant pathway in the development and progression of liver diseases and points out that Nrf2 may be a potential target for the prevention or treatment of liver diseases.
- liver diseases /
- NF-E2-related factor 2 /
- oxidative stress /
- review

HTML全文

参考文献(37)

[1]WANG WH, XU WH. Roles of Nrf2 and autophagy in liver fibrosis[J]. J Clin Hepatol, 2015, 31 (3) :447-451. (in Chinese) 王维昊, 许伟华.核因子E2相关因子2与细胞自噬对肝纤维化的影响[J].临床肝胆病杂志, 2015, 31 (3) :447-451.

[2]ZHU R, WANG Y, ZHANG L, et al. Oxidative Stress and liver disease[J]. Hepatol Res, 2012, 42 (8) :741-749.

[3]ELISABETTA C, TOMMASO M, ANDREA G. Pathogenesis of alcoholic liver disease:Role of oxidative metabolism[J].World J Gastroenterol, 2014, 20 (47) :17756-17772.

[4]CAI SM. The effect Angiotensin II/Angiotensin (1-7) on redox balance in liver fibrosis[D]. Guangzhou:Southern Medical University, 2014. (in Chinese) 蔡双明.血管紧张素Ⅱ/血管紧张素1-7通过调节氧化/抗氧化平衡影响肝纤维化的作用及机制[D].广州:广州南方医科大学, 2014.

[5]MOI P, CHAN K, ASUNIS I, et al. Isolation of NF-E2-related 2 (Nrf2) , a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region[J]. Proc Natl Acad Sci USA, 1994, 91 (21) :9926-9930.

[6]KOBAYASHI M, YAMAMOLO M. Nrf2-keap1-regulation of cellular defense mechanisms against electrophiles and reactive oxygen species[J]. Ade Enzyme Regul, 2006, 46:113-140.

[7]XU W, SHAO L, ZHOU C, et al. Upregulation of Nrf2 expression in non-alcoholic fatty liver and steatohepatitis[J]. Hepatogastroenterology, 2011, 58 (112) :2077-2080.

[8]LI H, DUAN HJ. Nrf2/ARE pathway and downstream antioxidant genes[J]. Chin Pharmacol bull, 2011, 27 (3) :300-303. (in Chinese) 李航, 段惠军. Nrf2/ARE信号通路及其调控的抗氧化蛋白[J].中国药理学通报, 2011, 27 (3) :300-303.

[9]KUMAR H, KIM I S, MONE SV, et al. Nature product-derived pharmacological modulators of Nre/ARE pathway for chronic disease[J]. Nat Prod Rep, 2014, 31 (1) :109-139.

[10]STEWART D, KILLEEN E, NAQUIN R, et al. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium[J]. J Biol Chem, 2003, 278:2396-2402.

[11]NGUYEN T, SHERRATTh PJ, HUANG HC, et al. Increased protein stabili-ty as a mechanism that enhances Nrf2-mediated transcriptional ac-tivation of the antioxidant response element:Degradation of Nrf2 by the 26S proteasome[J]. J Biol Chem, 2003, 278:4536-4541.

[12]ALEKSUNES LM, MANAUTOU J. Emerging role of Nrf2 in protecting againest hepatic and gastrointestinal disease[J]. Toxicol Pathol, 2007, 35 (4) :459-473.

[13]WANG YP, CHENG ML. Nrf2-keap1 antioxidant system and liver disease[J]. World Chin J Dig, 2010, 18 (18) :1907-1911. (in Chinese) 王豫萍, 程明亮. Nrf2-keap1抗氧化系统与肝脏疾病[J].世界华人消化杂志, 2010, 18 (18) :1907-1911.

[14]SCHACDLER S, KRAUSE J, HIMMCLSBACH K, et al. Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2[J]. J Biol Chem, 2010, 285 (52) :41074-41086.

[15]BENN J, SCHNEIDER RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade[J]. Proc Natl Acad Sci USA, 1994, 91 (22) :10350-10354.

[16]SEREN O, RLER G, OZLEM GULBAHAR OB. Serum levels of advanced oxidation protein products. malonyldialdehyde. and total radical trapping antioxidant parameter in patients with chronic hepatitis C[J]. Turk J Gastroenterol, 2011, 22:47-53.

[17]BURDETTE D, OLIVAREZ M, WARIS G. Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway[J]. J Gen Virol, 2010, 91 (3) :681-690.

[18]LEE JC, TSENG CK, YOUNG KC, et al. Andrographolide exerts anti-hepatitis Cvirus activity by up-regulating haeme oxygenasel via the p38 MAPA/Nrf2 pathway in human hepatoma cells[J]. Br J Pharmacol, 2014, 171:237-252.

[19]JING SUN, JINGQI FU, LU LI, et al. Nrf2 in alcoholic liver disease[J]. Toxicol Appl Pharmacol, 2018, 357:62-69.

[20]GONG P, CEDERBAUM Al. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1[J]. Hepatology, 2006, 43:144-153.

[21]WANG Z, DOU X, LI S, et al. Nuclear factor (erythroid-derived 2) -like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice[J].Hepatology, 2014, 59 (4) :1381-1392.

[22]CHOWDHRY S, NAZMY MH, MEAKIN PJ, et al. Loss of Nrf2markedly exacerbates nonalcoholic steatohepatitis[J]. Free Radic Biol Med, 2010, 48 (2) :357-371.

[23]ZENG C, ZHONG P, ZHAO Y, et al. Curcumin protects hearts from FFA-induced ingury by activating Nrf2 and inactivating NF-kB both in vitro and in vivo[J]. J Mol Cell Cardiol, 2015, 79:1-12.

[24]GOLDRING CE, KILLERINGHAM NB, ELSBY R, et al. Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice[J]. Hepatalogy, 2014, 39 (5) :1267-1276.

[25]REISMAN SA, BUCKLEY DB, TANAKA Y, et al. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes[J]. Toxicol Appl Pharmacol, 2009, 236 (1) :109-114.

[26]WEERACHAYAPHORN J, MENNONE A, SOROKA CJ, et al.Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine[J]. Am J Physiol Gastrointest Liver Physiol, 2012, 302 (9) :g925-g936.

[27]OKAD K, SHODA J, TAGUCHI K, et al. Nrf2 counteracts cholestatic liver ingury via stimulation of hepatic defense systems[J]. Biochem Biophys Res Commun, 2009, 389 (3) :431-436.

[28]PAN PH, LIN SY, WANG YY. Protective effects of rutin on liver injury induced by biliary obstruction in rats[J]. Free Radic Biol Med, 2014, 73:106-116.

[29]DING JB, LI XH. Current perspectives on the role of autophagy in liver fibrosis[J]. J Clin Hepatol, 2013, 29 (4) :305-307. (in Chinese) 丁剑波, 李秀慧.细胞自噬在肝纤维化中的作用[J].临床肝胆病杂志, 2013, 29 (4) :305-307.

[30]FRIEDMAN SL. Hepatic stellate cells:Protean, multifunctional and enigmatic cells of the liver[J]. Physiol Rev, 2008, 88 (1) :125-172.

[31]MAJ Q, DING J, ZHANG L, et al. Protective effect of urslic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway[J]. Clin Res Hepatol Gastroenterol, 2015, 39 (2) :188-197.

[32]WANG QM, DU JL, DUAN ZJ, et al. Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation[J]. World J Gastroenterol, 2013, 19 (19) :2921-2934.

[33]XU W, HELLERBRAN C, KOHLER UA, et al. The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis[J]. Lab Invest, 2008, 88 (10) :1068-1078.

[34]OH CJ, KIM JY, MIN AK, et al. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta/Smad signaling[J]. Free Radic Biol Med, 2012, 52 (3) :671-682.

[35]KAWATA K, KOBAYASHI Y, SOUDA K, et al. Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis[J]. Antioxid Redox Signal, 2010, 13 (3) :259-268.

[36]CHEN S, ZOU L, LI L, et al. The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2[J]. PLo S One, 2013, 8 (1) :e53662.

[37]BISHAYEE A, BARNES KF, BHATIA D, et al. Resveratrol suppresses oxidative stress and inflammatory response in diet hylnitrosamine initiated rat hepatoca rcinogenesis[J]. Cancer Prev Res (Phila) , 2010, 3 (6) :753-763.

施引文献

资源附件(0)

访问统计